Phase 2 Prospective Trial of Personalized Radiation Therapy Fractionation in Human Papillomavirus Positive Oropharyngeal Cancer
Personalized RT fractionation based on PSI suggests a promising rate of midtreatment response with favorable LF, PFS, and OS.
Authors
- Jameel Muzaffar (ORCID: https://orcid.org/0000-0003-3065-0269)
- Kedar Kirtane (ORCID: https://orcid.org/0000-0003-1302-9577)
- Maliha Zahid (ORCID: https://orcid.org/0000-0002-2986-9557)
- Julie A. Kish
- M. Echevarria
- Heiko Enderling
- Jimmy J. Caudell
- Youngchul Kim
- Christine Chung
- George Yang
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Duke University (US)
- Moffitt Cancer Center (US)
Publication Details
- Journal
- International Journal of Radiation Oncology*Biology*Physics
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.ijrobp.2025.12.053
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00